I’ve decided to go ahead & book profits on the remainder of my biotech short positions, including the LABU short. I’ll leave LABU on as an Active Short Trade for the time as I still believe there the biotech sector has more downside in the coming months although it appears that the odds for a meaningful rally are quite elevated at this time. In fact, I’ve even reversed to a modest long position. Charts to follow as soon as I get the chance to annotated & post them.